Notice of Participation of the National Human Genome Research Institute (NHGRI) in PA-20-163: Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)
Notice Number:
NOT-HG-23-021

Key Dates

Release Date:

February 21, 2023

Related Announcements

PA-20-163 - Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)

NOT-HG-23-023 - Notice of Special Interest (NOSI): Competitive Revisions for Maintenance and Integration of the Encyclopedia of DNA Elements (ENCODE) Data Resource

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice of Participation is to add the National Human Genome Research Institute (NHGRI) to the list of participating NIH Institutes in the Notice of Funding Opportunity (NOFO) PA-20-163 - Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional). The changes are bold-italicized.

Components of Participating Organizations

Current Language:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

Updated Language:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Environmental Health Sciences (NIEHS)

National Human Genome Research Institute (NHGRI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

Current Language:

93.847, 93.113

Updated Language:

93.847, 93.113; 93.172

All other aspects of this NOFO remain the same.

Inquiries

Please direct all inquiries to:

Bettie J. Graham, PhD
National Human Genome Research Institute (NHGRI)
Phone: 301-496-7531
Email: [email protected]